Home › Funds › INFINITUM ASSET MANAGEMENT, LLC › BHVN

INFINITUM ASSET MANAGEMENT, LLC position in BHVN

BIOHAVEN LTD · Health Care

INFINITUM ASSET MANAGEMENT, LLC reported holding 6,250,000 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$93.0M, representing 9.46% of its reported portfolio and ranking #4 among its reported holdings. INFINITUM ASSET MANAGEMENT, LLC has disclosed BHVN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)6.25M sh
Reported value held$93.00M
Portfolio Weight9.46%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How INFINITUM ASSET MANAGEMENT, LLC's BHVN position evolved

INFINITUM ASSET MANAGEMENT, LLC first disclosed a stake in BHVN in Q4 2024 at 110,000 shares (US$4.1M). The position peaked in Q2 2026 at 6,250,000 shares, worth US$93.0M. Across 7 filings, INFINITUM ASSET MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 6,250,000 shares valued at US$93.0M. Notable position changes include a 173% increase in Q1 2025 (shares fell 41% over the following quarter), a 209% increase in Q3 2025 (shares fell 25% over the following quarter), a 268% increase in Q4 2025 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 110.00K $4.11M New
Q1 2025 300.00K $7.21M Add
Q2 2025 550.00K $7.76M Add
Q3 2025 1.70M $25.52M Add
Q4 2025 6.25M $70.56M Add
Q1 2026 6.25M $52.88M Hold
Q2 2026 6.25M $93.00M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BHVN and 13F data

BHVN (BIOHAVEN LTD) is a Health Care company. 29 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), Royalty Pharma Sub-Manager, LLC (US$43.7M), Cormorant Asset Management, LP (US$38.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BHVN

All BHVN fund holders →

FAQ

How long has INFINITUM ASSET MANAGEMENT, LLC held BHVN?

INFINITUM ASSET MANAGEMENT, LLC has disclosed BHVN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is INFINITUM ASSET MANAGEMENT, LLC's current position in BHVN?

As of Q2 2026, INFINITUM ASSET MANAGEMENT, LLC holds 6.25M shares of BHVN (BIOHAVEN LTD), valued at $93.00M, representing 9.46% of its reported portfolio and ranking #4.

Has INFINITUM ASSET MANAGEMENT, LLC been buying or selling BHVN?

In the latest 13F filing (Q2 2026), INFINITUM ASSET MANAGEMENT, LLC held unchanged its position in BHVN. The position peaked in Q2 2026 at 6.25M shares.

Which other funds hold BHVN?

Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, Royalty Pharma Sub-Manager, LLC, Cormorant Asset Management, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.